(Q79164933)

English

Coax, COX and cola

scientific article published on October 20, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14558859%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Coax, COX and cola (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14558859%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

John S. Dowden

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14558859

21 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14558859

21 March 2024

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14558859%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

20 October 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14558859

21 March 2024

number of pages

2

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2003.tb05613.x

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

https://onlinelibrary.wiley.com/doi/full-xml/10.5694/j.1326-5377.2003.tb05613.x

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

Medical Journal of Australia

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14558859%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

179

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14558859%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14558859%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

397-398

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14558859%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

4

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

5

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice

6

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

7

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

Are selective COX 2 inhibitors superior to traditional NSAIDs? Little is known about COX 2 inhibitors

8

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

Reporting of 6-month vs 12-month data in a clinical trial of celecoxib

9

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

Risk of cardiovascular events associated with selective COX-2 inhibitors

10

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs

12

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

Pharmaceutical advertisement claims in Australian medical publications

14

1 reference

10.5694/J.1326-5377.2003.TB05613.X

https://api.crossref.org/works/10.5694/J.1326-5377.2003.TB05613.X

21 March 2024

Identifiers

10.5694/J.1326-5377.2003.TB05613.X

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14558859%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79164933&oldid=2108529749"